Granahan Investment Management - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,168,515
-34.9%
136,137
-16.9%
0.13%
-35.2%
Q4 2022$6,405,827
+21.8%
163,790
+48.3%
0.20%
+14.0%
Q3 2022$5,261,000
+67.9%
110,435
+36.5%
0.17%
+60.7%
Q2 2022$3,133,000
-49.5%
80,928
-25.2%
0.11%
-30.5%
Q1 2022$6,201,000
-6.7%
108,227
+29.8%
0.15%
+12.4%
Q4 2021$6,646,000
-15.9%
83,392
-8.2%
0.14%
-8.7%
Q3 2021$7,904,000
-40.1%
90,840
-11.4%
0.15%
-39.0%
Q2 2021$13,196,000
+70.7%
102,523
+6.1%
0.25%
+50.0%
Q1 2021$7,731,000
-17.0%
96,591
-15.3%
0.16%
-21.5%
Q4 2020$9,312,000
+296.9%
114,058
+19.7%
0.21%
+161.2%
Q3 2020$2,346,000
-13.3%
95,285
-1.4%
0.08%
-18.4%
Q2 2020$2,705,000
+52.9%
96,598
-1.7%
0.10%
+3.2%
Q1 2020$1,769,00098,2760.10%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$56,443,76354.70%
HSG Holding Ltd 796,089$19,145,9402.05%
Redmile Group, LLC 1,469,725$35,346,8861.68%
ARK Investment Management 8,783,891$211,252,5901.62%
Casdin Capital, LLC 570,000$13,708,5001.52%
Deep Track Capital, LP 1,015,641$24,426,1660.94%
Yiheng Capital Management, L.P. 560,500$13,480,0250.69%
Temasek Holdings (Private) Ltd 4,317,789$103,842,8250.62%
FARALLON CAPITAL MANAGEMENT LLC 4,481,839$107,788,2280.54%
Alphabet Inc. 321,604$7,734,5760.50%
View complete list of BEAM THERAPEUTICS INC shareholders